Skip to content
TrialScanner

NCT04325035

The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock

Phase 2CompletedWINTLead

Registry record

Lead sponsor
Windtree Therapeutics
Conditions
Cardiogenic Shock
Primary completion
Sep 26, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04325035 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04325035: The Safety and Efficacy of... | TrialScanner